Clinical Trials
31 trialsNCT07605897 2026-05-26
Assessment of Safety, Quality, and Acceptance of a Bowel Preparation Using a Food Kit With Laxatives
Hunter Holmes Mcguire Veteran Affairs Medical Center
Phase 4 Completed
NCT04764292 2026-05-22
SCEMAM
University of Pittsburgh
Phase 4 Completed
NCT03610022 2026-05-19
OPTIVISMO-1
University Hospital, Bordeaux
Phase 4 Completed
NCT07588828 2026-05-15
seroma
Ittefaq Hospital trust
Phase 4 Completed
NCT01742299 2026-05-14
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
Novartis
Phase 4 Completed
NCT06604442 2026-05-12
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Blue Earth Diagnostics
Phase 4 Completed
NCT03934684 2026-05-11
Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma
Amgen
Phase 4 Completed
NCT04745910 2026-05-06
Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome
M.D. Anderson Cancer Center
Phase 4 Completed
NCT06625047 2026-04-29
Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
Mayo Clinic
Phase 4 Completed
NCT05864846 2026-04-27
EpiCom
Jazz Pharmaceuticals
Phase 4 Completed
NCT01574170 2026-04-17
METAL3
Institut Claudius Regaud
Phase 4 Completed
NCT06427811 2026-04-17
ASC4INDIA
Novartis
Phase 4 Completed
NCT01127295 2026-04-14
PHACS
Institut Claudius Regaud
Phase 4 Completed
NCT01553903 2026-04-14
OXYTAM
Institut Claudius Regaud
Phase 4 Completed
NCT01612871 2026-04-14
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT03514381 2026-04-14
IPIAP-STM
Institut Claudius Regaud
Phase 4 Completed
NCT05651282 2026-04-13
RESToRE
University of British Columbia
Phase 4 Completed
NCT05110196 2026-04-07
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Phase 4 Completed
NCT05365230 2026-04-07
A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer
Ottawa Hospital Research Institute
Phase 4 Completed
NCT05631795 2026-04-07
ALPINIST
Novartis
Phase 4 Completed
NCT02555748 2026-03-31
SUP-R
Institut Claudius Regaud
Phase 4 Completed
NCT04266665 2026-03-25
Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome
Aristotle University Of Thessaloniki
Phase 4 Completed
NCT07487129 2026-03-23
Clinical and P
Beni-Suef University
Phase 4 Completed
NCT04948463 2026-03-20
ELSA-FN
Murdoch Childrens Research Institute
Phase 4 Completed
NCT06013098 2026-03-18
DOICA-E
China Medical University, China
Phase 4 Completed
NCT00904410 2026-03-13
CHIMTEP
Centre Oscar Lambret
Phase 4 Completed
NCT03151213 2026-03-13
pregabalin
Tanta University
Phase 4 Completed
NCT03573960 2026-03-06
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Eisai Inc.
Phase 4 Completed
NCT04024254 2026-03-04
A Study of Serum Folate Levels in Patients Treated With Olaparib
Rush University Medical Center
Phase 4 Completed
NCT03348969 2026-03-03
NICSA
Aarhus University Hospital
Phase 4 Completed
NCT04016376 2026-03-03
Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction
Memorial Sloan Kettering Cancer Center
Phase 4 Completed